Venous Thrombo-Embolism Imaging Database (VTE-ID)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2208 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-14

Study Completion Date

2021-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to identify and validate new imaging biomarkers allowing an individual phenotyping of patient with venous thrombo-embolism (VTE), mainly in terms of recurrence risk assessment and to distinguish provoked from unprovoked VTE. To do so, the investigators will create a retrospective imaging database including multiple imaging modalities, performed at diagnosis of the VTE.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)

NCT06057844

Venous Thromboembolism (VTE)

RECRUITING NA

Cancer-related Venous Thromboembolic Disease - Cohort Study

NCT06393764

Thrombosis Embolism Thromboses, Venous Cancer

NOT_YET_RECRUITING

Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism

NCT04304651

Embolism and Thrombosis

RECRUITING NA

Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )

NCT00805246

Pulmonary Embolism

COMPLETED

Prevalence of Pulmonary Embolism in ICU

NCT01457963

Pulmonary Embolism Deep Venous Thrombosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using a large imaging data in VTE (including ultrasound, CT-scan and Ventilation/Perfusion lung scan), the investigators will search for association between imaging data and VTE phenotypes, mainly in terms of recurrence risk assessment and to distinguish provoked from unprovoked VTE. Then, using a radiomic approach, the investigators will try to identify new imaging biomarkers able to provide an individual phenotyping in these patients.

These imaging biomarkers will be validated using an internal cross validation technique.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism Deep Vein Thrombosis Pulmonary Embolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older.
* Confirmed VTE diagnosis (deep vein thrombosis or pulmonary embolism).
* Inclusion in the EDITH (Etude des Déterminants et Interaction de la THrombose veineuse) between November 2009 and November 2019.
* No opposition to be included in the present study.

Exclusion Criteria

* Patients under 18 years old.
* Patients under judicial protection.
* Patient physically or cognitively unable to give consent.
* Refusal to participate.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No